Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide PK/PD in Adolescents with T2DM
NCT00254254Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2006
- Primary completion
- Feb 2007
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started Feb 2006; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00254254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254254.